Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 21 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

38%

8 trials in Phase 3/4

Results Transparency

0%

0 of 15 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
6(37.5%)
N/A
4(25.0%)
Phase 4
2(12.5%)
Phase 1
2(12.5%)
Phase 2
2(12.5%)
16Total
Phase 3(6)
N/A(4)
Phase 4(2)
Phase 1(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (21)

Showing 20 of 21 trials
NCT06905834Phase 2Not Yet Recruiting

Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments

Role: collaborator

NCT06985875Phase 3Not Yet Recruiting

Clinical Trial for the Evaluation of Safety and Efficacy of Drop 0.4%

Role: collaborator

NCT05706220Enrolling By Invitation

Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis

Role: lead

NCT03884569Not Yet Recruiting

Cultivated Limbal Epithelial Transplantation (CLET) for Limbal Stem Cell Deficiency (LSCD)

Role: lead

NCT05187533Not ApplicableCompleted

Sphenopalatine Ganglion Stimulation for Ocular and Oral Dryness

Role: lead

NCT05039684Recruiting

Inflammatory Biomarkers in Ocular Surface in Primary Open Angle Glaucoma or Ocular Hypertension Under Topical Prostaglandins

Role: lead

NCT00967850Phase 3Completed

Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High Myopia

Role: lead

NCT05290727Not ApplicableCompleted

Efficacy of "Aquoral Lipo" Artificial Tears in Contact Lens Wearers With Discomfort

Role: lead

NCT00309192Phase 3Completed

Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular Edema

Role: lead

NCT01716026Phase 3Completed

Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High Myopia

Role: lead

NCT04068272Phase 1Completed

Safety of Bosentan in Type II Diabetic Patients

Role: collaborator

NCT04937725Completed

Reading Problems Associated With Central Nervous System (CNS) Pathologies.

Role: lead

NCT04972695Completed

Validation of an Automatic Analysis Algorithm of the Probability of Glaucoma From Optic Disc Images

Role: lead

NCT04985097Not ApplicableCompleted

Home-based Visual Training in Patients Implanted With Trifocal Diffractive Intraocular Lenses

Role: collaborator

NCT03843983Not ApplicableCompleted

Effect of Thermal Pulsation System (Lipiflow) Treatment for Ocular Surface Disease Due to Meibomian Gland Dysfunction

Role: lead

NCT04492878Phase 4Completed

Efficacy and Safety of Ikervis Under Controlled Environmental Conditions Environment

Role: lead

NCT03173638Phase 2Unknown

Safety Assessment of Intravitreal Mesenchymal Stem Cells for Acute Non Arteritic Anterior Ischemic Optic Neuropathy

Role: lead

NCT01562002Phase 1Completed

Safety Study of Stem Cell Transplant to Treat Limbus Insufficiency Syndrome

Role: lead

NCT01742884Phase 4Completed

Efficacy and Safety of a Treatment for Dry Eye Syndrome: Thealoz

Role: lead

NCT02051023Phase 3Completed

Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca)

Role: lead